Please enable JavaScript to continue using this application.

Compare $BMRN vs $KYMR | Chartloom

Compare

$BMRN vs $KYMR

BioMarin Pharmaceutical Inc · Kymera Therapeutics Inc

BMRN

BioMarin Pharmaceutical Inc

KYMR

Kymera Therapeutics Inc

Compare $BMRN vs $KYMR

Comparing BioMarin Pharmaceutical Inc and Kymera Therapeutics Inc

BMRNBioMarin Pharmaceutical Inc

KYMRKymera Therapeutics Inc

BMRNBioMarin Pharmaceutical Inc

Market cap

$10.59B

P/E (TTM)

146.03x

Forward P/E (NTM)

12.82x

Forward P/S (NTM)

2.41x

Rev growth (TTM)

11.2%

YTD performance

-7.8%

52W performance

0.2%

FCF yield

6.8%

KYMRKymera Therapeutics Inc

Market cap

$9.25B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

456.91x

Rev growth (TTM)

134.8%

YTD performance

54.5%

52W performance

99.7%

FCF yield

-2.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMRN

KYMR

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

KYMR

Kymera Therapeutics Inc

Market Cap

BMRN$10.59B

KYMR$9.25B

Enterprise Value

BMRN$13.90B

KYMR$9.12B

Price

BMRN$54.80

KYMR$112.40

P/E Ratio

BMRN146.03x

KYMRN/A

P/S Ratio

BMRN3.11x

KYMR88.06x

EV/Sales

BMRN4.08x

KYMR86.90x

EV/EBITDA

BMRN16.77x

KYMR0.00x

P/B Ratio

BMRN1.75x

KYMR5.92x

P/FCF Ratio

BMRN14.61x

KYMRN/A

EV/FCF

BMRN19.17x

KYMR-38.34x

PEG Ratio

BMRN4.10x

KYMRN/A

Forward P/E (NTM)

BMRN12.82x

KYMRN/A

Forward P/S (NTM)

BMRN2.41x

KYMR456.91x

Revenue (TTM)

BMRN$3.41B

KYMR$105M

Revenue Growth (YoY)

BMRN11.2%

KYMR134.8%

Forward Rev Growth

BMRN14.5%

KYMR-62.1%

Gross Margin (TTM)

BMRN79.6%

KYMR0.0%

Operating Margin (TTM)

BMRN4.4%

KYMR0.0%

EBITDA Margin (TTM)

BMRN24.3%

KYMR-322.0%

Net Margin (TTM)

BMRN2.1%

KYMR-285.3%

FCF Margin (TTM)

BMRN21.3%

KYMR-226.6%

Net Income (TTM)

BMRN$73M

KYMR$-300M

FCF (TTM)

BMRN$725M

KYMR$-238M

EPS (TTM)

BMRN$0.38

KYMR-$3.05

ROE (TTM)

BMRN1.2%

KYMR-2150.0%

ROA (TTM)

BMRN82.0%

KYMR-1946.0%

ROIC (TTM)

BMRN93.0%

KYMR-2145.0%

Cash

BMRN$874M

KYMR$124M

Debt

BMRN$4.19B

KYMR$2M

Net Cash/Debt

BMRN$-3.31B

KYMR$122M

Current Ratio (TTM)

BMRN2.39x

KYMR10.34x

Quick Ratio (TTM)

BMRN1.16x

KYMR9.97x

Debt/Equity (TTM)

BMRN0.66x

KYMR0.00x

Debt/Assets (TTM)

BMRN0.0%

KYMR0.0%

Interest Coverage (TTM)

BMRNN/A

KYMRN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

KYMR0.00x

Beta

BMRN0.23

KYMR2.05

52W Performance

BMRN0.2%

KYMR99.7%

YTD Performance

BMRN-7.8%

KYMR54.5%

% from 52W High

BMRN-22.8%

KYMR-13.6%

% from 52W Low

BMRN11.2%

KYMR103.4%

Asset Turnover (TTM)

BMRN0.38x

KYMR0.07x

FCF Yield (TTM)

BMRN6.8%

KYMR-2.6%

Earnings Yield (TTM)

BMRN0.7%

KYMR-3.2%

Dividend Yield (TTM)

BMRNN/A

KYMRN/A

Rule of 40

BMRN32.5

KYMR-91.8

EV/GP/RG

BMRN0.18

KYMRN/A

Ticker research

View BMRN research View KYMR research

Metric	BMRN BioMarin Pharmaceutical Inc	KYMR Kymera Therapeutics Inc
Market & Valuation
Market Cap	$10.59B	$9.25B
Enterprise Value	$13.90B	$9.12B
Price	$54.80	$112.40
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	88.06x
EV/Sales	4.08x	86.90x
EV/EBITDA	16.77x	0.00x
P/B Ratio	1.75x	5.92x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-38.34x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	456.91x
Revenue & Growth
Revenue (TTM)	$3.41B	$105M
Revenue Growth (YoY)	11.2%	134.8%
Forward Rev Growth	14.5%	-62.1%
Profitability
Gross Margin (TTM)	79.6%	0.0%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	-322.0%
Net Margin (TTM)	2.1%	-285.3%
FCF Margin (TTM)	21.3%	-226.6%
Net Income (TTM)	$73M	$-300M
FCF (TTM)	$725M	$-238M
EPS (TTM)	$0.38	-$3.05
ROE (TTM)	1.2%	-2150.0%
ROA (TTM)	82.0%	-1946.0%
ROIC (TTM)	93.0%	-2145.0%
Financial Health
Cash	$874M	$124M
Debt	$4.19B	$2M
Net Cash/Debt	$-3.31B	$122M
Current Ratio (TTM)	2.39x	10.34x
Quick Ratio (TTM)	1.16x	9.97x
Debt/Equity (TTM)	0.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	2.05
52W Performance	0.2%	99.7%
YTD Performance	-7.8%	54.5%
% from 52W High	-22.8%	-13.6%
% from 52W Low	11.2%	103.4%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.07x
FCF Yield (TTM)	6.8%	-2.6%
Earnings Yield (TTM)	0.7%	-3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	-91.8
EV/GP/RG	0.18	N/A
Ticker research	View BMRN research	View KYMR research

Valuation

P/E Ratio

BMRN

146.03x

P/S Ratio

BMRN

3.11x

KYMR

88.06x

EV/FCF

KYMR

-38.34x

BMRN

19.17x

Growth & revenue

Revenue Growth TTM

KYMR

134.8%

BMRN

11.2%

Forward Revenue Growth

BMRN

14.5%

KYMR

-62.1%

Profitability & performance

Gross Margin

BMRN

79.6%

KYMR

0.0%

ROE

BMRN

1.2%

KYMR

-2150.0%

FCF Yield %

BMRN

6.8%

KYMR

-2.6%

52-Week Performance

KYMR

99.7%

BMRN

0.2%

Detailed metrics comparison

BMRN

BioMarin Pharmaceutical Inc

KYMR

Kymera Therapeutics Inc

Market Cap

BMRN$10.59B

KYMR$9.25B

Enterprise Value

BMRN$13.90B

KYMR$9.12B

Price

BMRN$54.80

KYMR$112.40

P/E Ratio

BMRN146.03x

KYMRN/A

P/S Ratio

BMRN3.11x

KYMR88.06x

EV/Sales

BMRN4.08x

KYMR86.90x

EV/EBITDA

BMRN16.77x

KYMR0.00x

P/B Ratio

BMRN1.75x

KYMR5.92x

P/FCF Ratio

BMRN14.61x

KYMRN/A

EV/FCF

BMRN19.17x

KYMR-38.34x

PEG Ratio

BMRN4.10x

KYMRN/A

Forward P/E (NTM)

BMRN12.82x

KYMRN/A

Forward P/S (NTM)

BMRN2.41x

KYMR456.91x

Revenue (TTM)

BMRN$3.41B

KYMR$105M

Revenue Growth (YoY)

BMRN11.2%

KYMR134.8%

Forward Rev Growth

BMRN14.5%

KYMR-62.1%

Gross Margin (TTM)

BMRN79.6%

KYMR0.0%

Operating Margin (TTM)

BMRN4.4%

KYMR0.0%

EBITDA Margin (TTM)

BMRN24.3%

KYMR-322.0%

Net Margin (TTM)

BMRN2.1%

KYMR-285.3%

FCF Margin (TTM)

BMRN21.3%

KYMR-226.6%

Net Income (TTM)

BMRN$73M

KYMR$-300M

FCF (TTM)

BMRN$725M

KYMR$-238M

EPS (TTM)

BMRN$0.38

KYMR-$3.05

ROE (TTM)

BMRN1.2%

KYMR-2150.0%

ROA (TTM)

BMRN82.0%

KYMR-1946.0%

ROIC (TTM)

BMRN93.0%

KYMR-2145.0%

Cash

BMRN$874M

KYMR$124M

Debt

BMRN$4.19B

KYMR$2M

Net Cash/Debt

BMRN$-3.31B

KYMR$122M

Current Ratio (TTM)

BMRN2.39x

KYMR10.34x

Quick Ratio (TTM)

BMRN1.16x

KYMR9.97x

Debt/Equity (TTM)

BMRN0.66x

KYMR0.00x

Debt/Assets (TTM)

BMRN0.0%

KYMR0.0%

Interest Coverage (TTM)

BMRNN/A

KYMRN/A

Net Debt/EBITDA (TTM)

BMRN0.00x

KYMR0.00x

Beta

BMRN0.23

KYMR2.05

52W Performance

BMRN0.2%

KYMR99.7%

YTD Performance

BMRN-7.8%

KYMR54.5%

% from 52W High

BMRN-22.8%

KYMR-13.6%

% from 52W Low

BMRN11.2%

KYMR103.4%

Asset Turnover (TTM)

BMRN0.38x

KYMR0.07x

FCF Yield (TTM)

BMRN6.8%

KYMR-2.6%

Earnings Yield (TTM)

BMRN0.7%

KYMR-3.2%

Dividend Yield (TTM)

BMRNN/A

KYMRN/A

Rule of 40

BMRN32.5

KYMR-91.8

EV/GP/RG

BMRN0.18

KYMRN/A

Ticker research

View BMRN research View KYMR research

Metric	BMRN BioMarin Pharmaceutical Inc	KYMR Kymera Therapeutics Inc
Market & Valuation
Market Cap	$10.59B	$9.25B
Enterprise Value	$13.90B	$9.12B
Price	$54.80	$112.40
P/E Ratio	146.03x	N/A
P/S Ratio	3.11x	88.06x
EV/Sales	4.08x	86.90x
EV/EBITDA	16.77x	0.00x
P/B Ratio	1.75x	5.92x
P/FCF Ratio	14.61x	N/A
EV/FCF	19.17x	-38.34x
PEG Ratio	4.10x	N/A
Forward P/E (NTM)	12.82x	N/A
Forward P/S (NTM)	2.41x	456.91x
Revenue & Growth
Revenue (TTM)	$3.41B	$105M
Revenue Growth (YoY)	11.2%	134.8%
Forward Rev Growth	14.5%	-62.1%
Profitability
Gross Margin (TTM)	79.6%	0.0%
Operating Margin (TTM)	4.4%	0.0%
EBITDA Margin (TTM)	24.3%	-322.0%
Net Margin (TTM)	2.1%	-285.3%
FCF Margin (TTM)	21.3%	-226.6%
Net Income (TTM)	$73M	$-300M
FCF (TTM)	$725M	$-238M
EPS (TTM)	$0.38	-$3.05
ROE (TTM)	1.2%	-2150.0%
ROA (TTM)	82.0%	-1946.0%
ROIC (TTM)	93.0%	-2145.0%
Financial Health
Cash	$874M	$124M
Debt	$4.19B	$2M
Net Cash/Debt	$-3.31B	$122M
Current Ratio (TTM)	2.39x	10.34x
Quick Ratio (TTM)	1.16x	9.97x
Debt/Equity (TTM)	0.66x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	2.05
52W Performance	0.2%	99.7%
YTD Performance	-7.8%	54.5%
% from 52W High	-22.8%	-13.6%
% from 52W Low	11.2%	103.4%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.07x
FCF Yield (TTM)	6.8%	-2.6%
Earnings Yield (TTM)	0.7%	-3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	32.5	-91.8
EV/GP/RG	0.18	N/A
Ticker research	View BMRN research	View KYMR research